
Cost Drivers Report 2023
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic. Read the full report….
Our resource hub to discover reports, policy papers and other forms of informative content
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic. Read the full report….
Informative content to keep you up to date on the most pressing issues facing our industry.